Redefining Heart Failure With a Reduced Ejection Fraction

被引：45

作者：

Butler, Javed ^{[1
]}

Anker, Stefan D. ^{[2
,3
]}

Packer, Milton ^{[4
,5
]}

机构：

[1] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA

[2] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany

[3] Charite Univ Med Berlin, Dept Cardiol, German Ctr Cardiovasc Res Berlin, Berlin, Germany

[4] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA

[5] Imperial Coll, London, England

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2019年 / 322卷 / 18期

关键词：

ASSOCIATION; MIDRANGE;

D O I：

10.1001/jama.2019.15600

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this Viewpoint, Milton Packer and colleagues argue that reliance on a threshold of LVEF <= 40% to define heart failure with reduced ejection fraction (HFrEF) may exclude patients with impaired systolic function and subnormal LVEF from evidence-based treatments that reduce morbidity and mortality, and the authors propose that the LVEF threshold for HFrEF treatment be increased to <= 50%.

引用

页码：1761 / 1762

页数：2

共 50 条

[31] The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
Masarone, Daniele
Martucci, Maria Luigia
Errigo, Vittoria
Pacileo, Giuseppe
[J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (09)
[32] Neurohormonal activation in heart failure with reduced ejection fraction
Hartupee, Justin
Mann, Douglas L.
[J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (01) : 30 - 38
[33] Ventricular arrhythmias in heart failure with reduced ejection fraction
Voskoboinik, Aleksandr
Moss, Joshua D.
[J]. CURRENT OPINION IN CARDIOLOGY, 2020, 35 (03) : 282 - 288
[34] Management of Chronic Heart Failure with Reduced Ejection Fraction
Williamson, Brandon
Tong, Carl
[J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2024, 37 (03)
[35] Pharmacological therapy of heart failure with reduced ejection fraction
Wieser, Monika
Rhyner, Daniel
Martinelli, Michele
Suter, Thomas
Schnegg, Bruno
Bosch, Claudia
Wigger, Olivier
Dobner, Stephan
Hunziker, Lukas
[J]. THERAPEUTISCHE UMSCHAU, 2018, 75 (03) : 180 - 186
[36] Dapagliflozin in patients with heart failure and reduced ejection fraction
Giorgio Colombo
Rosa Casella
Alessia Cazzaniga
Chiara Casiraghi
[J]. Internal and Emergency Medicine, 2020, 15 : 515 - 517
[37] Dapagliflozin for patients with heart failure and reduced ejection fraction
Ferry, Abigail
[J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
[38] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V.
Solomon, S. D.
Inzucchi, S. E.
Kober, L.
Kosiborod, M. N.
Martinez, F. A.
Ponikowski, P.
Sabatine, M. S.
Anand, I. S.
Belohlavek, J.
Bohm, M.
Chiang, C. -E.
Chopra, V. K.
de Boer, R. A.
Desai, A. S.
Diez, M.
Drozdz, J.
Dukat, A.
Ge, J.
Howlett, J. G.
Katova, T.
Kitakaze, M.
Ljungman, C. E. A.
Merkely, B.
Nicolau, J. C.
O'Meara, E.
Petrie, M. C.
Vinh, P. N.
Schou, M.
Tereshchenko, S.
Verma, S.
Held, C.
DeMets, D. L.
Docherty, K. F.
Jhund, P. S.
Bengtsson, O.
Sjostrand, M.
Langkilde, A. -M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
[39] Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Armstrong, Paul W.
Pieske, Burkert
Anstrom, Kevin J.
Ezekowitz, Justin
Hernandez, Adrian F.
Butler, Javed
Lam, Carolyn S. P.
Ponikowski, Piotr
Voors, Adriaan A.
Jia, Gang
McNulty, Steven E.
Patel, Mahesh J.
Roessig, Lothar
Koglin, Joerg
O'Connor, Christopher M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1883 - 1893
[40] Updates in pharmacotherapy of heart failure with reduced ejection fraction
Espinoza, Clifton
Alkhateeb, Haider
Siddiqui, Tariq
[J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)

← 1 2 3 4 5 →